BlossomHill Therapeutics
PrivateLast Round
Series B
Extension
Dec 10, 2025
Total Funding Raised
$343.65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BlossomHill Therapeutics is a biopharmaceutical company that discovers and develops small molecule medicines for the treatment of high-need cancers and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlossomHill Therapeutics Comparables
Compare BlossomHill Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| J INTS BIO | 86% | |
| Theseus Pharmaceuticals | 82% | |
| Kestrel Therapeutics | 79% |
BlossomHill Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 10, 2025 | ||||
| Series B | Feb 29, 2024 | ||||
| Series B | Dec 28, 2023 | ||||
| Series A | Mar 3, 2021 |
Key People
Founding team and executive leadership
BlossomHill Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B Extension |
| Janus Henderson Group | Series B Extension |
| H&D Asset Management | Series B |
| Cormorant Asset Management | Series B, Series B Extension, Series A |
| OrbiMed | Series B, Series B Extension, Series A |
| Brahma Capital | Series B Extension |
| Plaisance Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 65% MoM, reaching 4.5K.
- Jun 30, 2026
Grew 17% QoQ, from 59 to 69 employees.
Recent news
Latest coverage and updates
- receives_financingAug 7, 2026
BlossomHill Therapeutics, Inc. received financing of $150M in IPO on Jul 1st '26.
- receives_financingAug 3, 2026
BlossomHill Therapeutics, Inc. was planning to receive financing of $112M in IPO on Aug 3rd '26.
- identified_as_competitor_ofAug 3, 2026
BlossomHill Therapeutics, Inc. was planning to identify as competitor of AstraZeneca group on Aug 3rd '26.
- goes_publicAug 3, 2026
BlossomHill Therapeutics, Inc. went public on Aug 3rd '26.
- goes_publicJul 20, 2026
bhtherapeutics.com is planning to go public.
BlossomHill Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BlossomHill Therapeutics's valuation, stock price, and market status.
Is BlossomHill Therapeutics a public or private company?
BlossomHill Therapeutics is a private company.
What is the current stock price of BlossomHill Therapeutics?
BlossomHill Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is BlossomHill Therapeutics worth (valuation)?
Valuation information for BlossomHill Therapeutics is not publicly available.
Can I buy BlossomHill Therapeutics stock?
BlossomHill Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BlossomHill Therapeutics's last funding round?
BlossomHill Therapeutics's most recent funding round was Series B Extension on December 10, 2025.
Who are the main investors in BlossomHill Therapeutics?
Key investors in BlossomHill Therapeutics include BioTrack Capital, Janus Henderson Group, Brahma Capital, Colt Ventures, Cormorant Asset Management.
Will BlossomHill Therapeutics IPO soon?
No public IPO plans have been announced for BlossomHill Therapeutics.
How can I track BlossomHill Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BlossomHill Therapeutics's secondary market activity and sign up for updates.